comparemela.com

Latest Breaking News On - Clinical research organisations - Page 7 : comparemela.com

Global Clinical Trials Packaging Market to be Driven by Customer Affinity for Sustainable Packaging and Growing Pharmaceutical Industry Across the Globe in the Forecast Period of 2021-2026

Global Clinical Trials Packaging Market to be Driven by Customer Affinity for Sustainable Packaging and Growing Pharmaceutical Industry Across the Globe in the Forecast Period of 2021-2026
texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.

CANKADO s Digital Health Solution Assists a New Clinical Trial, ADAPTlate

This oncologic clinical trial evaluates the efficacy and safety of the CDK 4/6 Inhibitor Abemaciclib in combination with endocrine therapy in high-risk early breast cancer patients Cologne, Germany, 07.01.2021 – CANKADO, the leading digital health application developers in Germany, assists the recently started clinical trial, ADAPTlate, organized by West German Study Group (WSG) to collect the Patient Reported Outcomes (PROs) by the CANKADO ePRO tool. The clinical trial already enrolled the first patients who are using the CANKADO e-Health system as part of the study to monitor their Quality of Life (QoL). The trial aims to gain further knowledge on the efficacy and safety of the Abemaciclib treatment in combination with endocrine therapy versus standard endocrine therapy in HR+/HER2- early breast cancer patients with high risk for disease recurrence.

CANKADO s Companion-APP Solution provides Drug-Optimised Digital Applications for Pharmaceutical Companies

The tool is a drug tailored extension of CANKADO’s e-Health solution Cologne, Germany, 17.12.2020 – CANKADO’s Companion-APP solution provides an environment that helps to build a drug-tailored digital connected care solution for physicians and their patients. Pharmaceutical companies can easily develop their own multi-dimensional drug-optimized digital support for every drug and treatment. It improves patient safety, increases patient compliance, and prolongs drug adherence for a better outcome. CANKADO Companion-APP is a complete solution comprising a family of medical devices according to EU and US regulations. It is built on CANKADO’s backbone structure that consists of patient’s records ensuring data security and privacy. It allows connection to healthcare professionals and includes the AI-driven PRO-React framework. Information extensions are integrated on Companion-APP, tailored for each drug/treatment. Pharma partners of CANKADO can build their own drug tailore

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.